2021
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study
Thomson MJ, Serper M, Khungar V, Weiss LM, Trinh H, Firpi-Morell R, Roden M, Loomba R, Barritt AS, Gazis D, Mospan AR, Fried MW, Reddy KR, Lok AS. Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study. Clinical Gastroenterology And Hepatology 2021, 20: 458-460.e4. PMID: 33775894, PMCID: PMC8464616, DOI: 10.1016/j.cgh.2021.03.031.Peer-Reviewed Original ResearchMeSH KeywordsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLiver CirrhosisLiver NeoplasmsNon-alcoholic Fatty Liver DiseasePrevalenceConceptsNonalcoholic fatty liver diseaseFatty liver diseaseLiver diseaseStatin useReal-world cohortCoenzyme reductase inhibitorsHepatic decompensationCardiovascular eventsPatient factorsCardiovascular diseasePatientsLower mortalityReductase inhibitorsStatinsDiseasePrevalenceRiskDecompensationCarcinomaHepatotoxicityCohortMortality
2019
Reducing Hospital Admissions for Paracentesis: A Quality Improvement Intervention
Siddique SM, Porges S, Lane-Fall M, Mehta SJ, Schweickert W, Kinniry J, Taylor A, Lewis JD, Iqbal S, Goldberg D, Shea JA, Stetson R, Coniglio M, Hoteit M, Fishman N, Khungar V. Reducing Hospital Admissions for Paracentesis: A Quality Improvement Intervention. Clinical Gastroenterology And Hepatology 2019, 17: 2630-2633.e2. PMID: 31518719, PMCID: PMC6874893, DOI: 10.1016/j.cgh.2019.09.001.Peer-Reviewed Original ResearchImproving cirrhosis care: The potential for telemedicine and mobile health technologies
Stotts MJ, Grischkan JA, Khungar V. Improving cirrhosis care: The potential for telemedicine and mobile health technologies. World Journal Of Gastroenterology 2019, 25: 3849-3856. PMID: 31413523, PMCID: PMC6689809, DOI: 10.3748/wjg.v25.i29.3849.Peer-Reviewed Original ResearchConceptsCare of patientsHeart failureHigh-value carePatient-reported outcome measuresLiver disease managementCare of veteransDownstream cost savingsMobile health technologyCirrhosis careHospital readmissionClinical outcomesLiver diseaseSignificant morbidityCancer screeningOutcome measuresCirrhosisPreventative careMortality rateClinical practicePatientsCareDisease managementQuality gapMobile healthHealth technologies